590
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Epidemiology of community-acquired sepsis in the Faroe Islands – a prospective observational study

ORCID Icon, , , &
Pages 38-49 | Received 02 May 2018, Accepted 07 Aug 2018, Published online: 21 Nov 2018

References

  • Czura C. Merinoff symposium 2010: sepsis-speaking with one voice. Mol Med. 2011;17:2.
  • Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009–2014. JAMA. 2017;318:1241–1249.
  • Global Sepis Alliance. Fact Sheet Sepsis. Serbest [Internet]. 2015;1–8. Available from: http://www.world-sepsis-day.org/toolkits
  • Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis – Current estimates and limitations. Am J Respir Crit Care Med. 2016;193:259–261.
  • Protect Your Patients From Sepsis Infographic [Internet]. Atlanta (GA): Centers for Disease Control; 2016; [cited 2017 Nov 15]. Available from: https://www.cdc.gov/sepsis/pdfs/HCP_infographic_protect-your-patients-from-sepsis_508.pdf
  • Micek ST, Roubinian N, Heuring T, et al. Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006;34:2707–2713.
  • Varpula M, Karlsson S, Parviainen I, et al. Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand. 2007;51:1320–1326.
  • Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589–1596.
  • Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit CareMed 2004;7:171–194.
  • Llewelyn MJ, Cohen J. Tracking the microbes in sepsis: advancements in treatment bring challenges for microbial epidemiology. Clin Infect Dis. 2007;44:1343–1348.
  • Whittaker SA, Mikkelsen ME, Gaieski DF, et al. Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population. Crit Care Med. 2013;41:945–953.
  • Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine . Chest 1992;101:1644–1655.
  • Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250–1256.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock. JAMA 2016;315:801–810.
  • Hagstova Føroya [Internet]. [cited 2017 Mar 20]. Available from: http://www.hagstova.fo/fo
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • Gaïni S, Koldkjaer OG, Møller HJ, et al. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study. Crit Care. 2007;11:R76–R10.
  • Henriksen DP, Laursen CB, Jensen TG, et al. Incidence rate of community-acquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med. 2015;43:13–21.
  • Stoller J, Halpin L, Weis M, et al. Epidemiology of severe sepsis: 2008–2012. J Crit Care 2016;31:58–62.
  • Wilhelms SB, Walther SM, Huss F, et al. Severe sepsis in the ICU is often missing in hospital discharge codes. Acta Anaesthesiol Scand. 2017;61:186–193.
  • Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8:222–226.
  • Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167–1174.
  • Flaatten H. Epidemiology of sepsis in Norway in 1999. Crit Care. 2004;8:R180–R184.
  • Esteban A, Frutos-Vivar F, Ferguson ND, et al. Sepsis incidence and outcome: contrasting the intensive care unit with the hospital ward. Crit Care Med. 2007;35:1284–1289.
  • Karlsson S. The incidence and outcome of severe sepsis in Finland The Finnsepsis Study [dissertation]. Finland: University of Helsinki; 2009.
  • Jawad I, Lukšić I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health. 2012;2:010404.
  • Padkin A, Goldfrad C, Brady AR, et al. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003;31:2332–2338.
  • Wilhelms SB, Huss FR, Granath G, et al. F. Assessment of incidence of severe sepsis in Sweden using different ways of abstracting International Classification of Diseases codes: difficulties with methods and interpretation of results. Crit Care Med. 2010;38:1442–1449.
  • Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care 2006;10:R42.
  • Finfer S, Bellomo R, Lipman J, et al. Adult-population incidence of severe sepsis in Australian and New Zeland intensive care units. Intensive Care Med. 2004;30:589–596.
  • Blanco J, Muriel-bombín A, Sagredo V, et al. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008; 12:R158.
  • Kumar G, Kumar N, Taneja A, et al. Nationwide trends of severe sepsis in the 21st century (2000–2007). Chest 2011;140:1223–1231.
  • Lagu T, Rothberg MB, Shieh M-S, et al. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40:754–761.
  • Van Gestel A, Bakker J, Veraart CP, et al. Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care. 2004;8:R153–R162.
  • Mellhammar L, Wullt S, Lindberg Å, et al. Sepsis incidence: a population-based study. Ofids. 2016;3:ofw207.
  • Vesteinsdottir E, Karason S, Sigurdsson SE, et al. Severe sepsis and septic shock: a prospective population-based study in Icelandic intensive care units. Acta Anaesthesiol Scand. 2011;55:722–731.
  • SepNet Critical Care Trials Group. Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med. 2016;42:1980–1989.
  • Alberti C, Brun-Buisson C, Burchardi H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108–121.
  • Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–1554.
  • Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310.
  • Wang HE, Shapiro NI, Angus DC, et al. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35:1928–1936.
  • Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244–1250.
  • Rhee C, Shruti G, Klompas M. Regulatory mandates for sepsis care-reasons for caution. N Engl J Med. 2014;370:1673–1676.
  • Binzer S, Stenager E, Binzer M, et al. Genetic analysis of the isolated Faroe Islands reveals SORCS3 as a potential multiple sclerosis risk gene. Mult Scler. 2016;22:733–740.
  • Rasmussen J, Nielsen OW, Janzen N, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014;37:215–222.
  • Santer R, Kinner M, Steuerwald U, et al. Molecular genetic basis and prevalence of glycogen storage disease type IIIA in the Faroe Islands. Eur J Hum Genet. 2001;9:388–391.
  • Weihe P, Mathiassen B, Rasmussen JM, et al. An epidemic outbreak of group b meningococcal disease on the Faroe islands. Scand J Infect Dis. 1988;20:291–296.
  • Heilmann C, Grandjean P, Weihe P, et al. Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med. 2006;3:e311–e319.
  • Sørensen TIA, Nielsen GG, Andersen PK, et al. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318:727–732.
  • Obel N, Christensen K, Petersen I, et al. Genetic and environmental influences on risk of death due to infections assessed in Danish twins, 1943–2001. Am J Epidemiol. 2010;171:1007–1013.
  • Knoop ST, Skrede S, Langeland N, et al. Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: a national retrospective study. PLoS One. 2017;12:e0187990–e0187914.
  • Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin Infect Dis. 2005; 41:S490– S497.
  • Schröder J, Kahlke V, Staubach K-H, et al. Gender differences in human sepsis. Arch Surg. 1998; 133:1200–1205.
  • Nygård ST, Langeland N, Flaatten HK, et al. Aetiology, antimicrobial therapy and outcome of patients with community-acquired severe sepsis: a prospective study in a Norwegian university hospital. BMC Infect Dis. 2014;14:121.
  • Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers epidemiology of sepsis syndrome. JAMA. 1997;278:234–240.
  • Danai PA, Sinha S, Moss M, et al. Seasonal variation in the epidemiology of sepsis. Crit Care Med. 2007;35:410–415.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.